These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 16446155)
1. Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652. Duncan RS; Ridley JM; Dempsey CE; Leishman DJ; Leaney JL; Hancox JC; Witchel HJ Biochem Biophys Res Commun; 2006 Mar; 341(2):500-6. PubMed ID: 16446155 [TBL] [Abstract][Full Text] [Related]
2. Block effect of capsaicin on hERG potassium currents is enhanced by S6 mutation at Y652. Xing J; Ma J; Zhang P; Fan X Eur J Pharmacol; 2010 Mar; 630(1-3):1-9. PubMed ID: 19903464 [TBL] [Abstract][Full Text] [Related]
3. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain. Duan JJ; Ma JH; Zhang PH; Wang XP; Zou AR; Tu DN Acta Pharmacol Sin; 2007 Jul; 28(7):959-67. PubMed ID: 17588331 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of HERG channels by the local anaesthetic articaine. Siebrands CC; Friederich P Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156 [TBL] [Abstract][Full Text] [Related]
5. High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656. Ridley JM; Milnes JT; Witchel HJ; Hancox JC Biochem Biophys Res Commun; 2004 Dec; 325(3):883-91. PubMed ID: 15541373 [TBL] [Abstract][Full Text] [Related]
6. Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-à-go-go-related gene channels. Perrin MJ; Kuchel PW; Campbell TJ; Vandenberg JI Mol Pharmacol; 2008 Nov; 74(5):1443-52. PubMed ID: 18701618 [TBL] [Abstract][Full Text] [Related]
7. Na+ permeation and block of hERG potassium channels. Gang H; Zhang S J Gen Physiol; 2006 Jul; 128(1):55-71. PubMed ID: 16769794 [TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform. Scholz EP; Alter M; Zitron E; Kiesecker C; Kathöfer S; Thomas D; Kreye VA; Kreuzer J; Becker R; Katus HA; Greten J; Karle CA Toxicol Lett; 2006 Aug; 165(2):156-66. PubMed ID: 16647228 [TBL] [Abstract][Full Text] [Related]
9. The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph. Chapman H; Pasternack M Eur J Pharmacol; 2007 Jan; 554(2-3):98-105. PubMed ID: 17109852 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656. Ridley JM; Milnes JT; Duncan RS; McPate MJ; James AF; Witchel HJ; Hancox JC FEBS Lett; 2006 Apr; 580(8):1999-2005. PubMed ID: 16542653 [TBL] [Abstract][Full Text] [Related]
11. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels. Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732 [TBL] [Abstract][Full Text] [Related]
12. Topological mapping of the asymmetric drug binding to the human ether-à-go-go-related gene product (HERG) potassium channel by use of tandem dimers. Myokai T; Ryu S; Shimizu H; Oiki S Mol Pharmacol; 2008 Jun; 73(6):1643-51. PubMed ID: 18326583 [TBL] [Abstract][Full Text] [Related]
13. The hERG potassium channel and drug trapping: insight from docking studies with propafenone derivatives. Thai KM; Windisch A; Stork D; Weinzinger A; Schiesaro A; Guy RH; Timin EN; Hering S; Ecker GF ChemMedChem; 2010 Mar; 5(3):436-42. PubMed ID: 20146282 [TBL] [Abstract][Full Text] [Related]
14. Analogs of MK-499 are differentially affected by a mutation in the S6 domain of the hERG K+ channel. Karczewski J; Wang J; Kane SA; Kiss L; Koblan KS; Culberson JC; Spencer RH Biochem Pharmacol; 2009 May; 77(10):1602-11. PubMed ID: 19426697 [TBL] [Abstract][Full Text] [Related]
15. Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers. Zachariae U; Giordanetto F; Leach AG J Med Chem; 2009 Jul; 52(14):4266-76. PubMed ID: 19534531 [TBL] [Abstract][Full Text] [Related]
16. Procaine, a state-dependent blocker, inhibits HERG channels by helix residue Y652 and F656 in the S6 transmembrane domain. Wang N; Ma JH; Zhang PH J Pharmacol Sci; 2013 Sep; 123(1):25-35. PubMed ID: 24005047 [TBL] [Abstract][Full Text] [Related]
17. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells. Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747 [TBL] [Abstract][Full Text] [Related]
18. Interaction simulation of hERG K+ channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition. Yi H; Cao Z; Yin S; Dai C; Wu Y; Li W J Proteome Res; 2007 Feb; 6(2):611-20. PubMed ID: 17269718 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic characterization of a novel hERG channel activator. Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel. Stanat SJ; Carlton CG; Crumb WJ; Agrawal KC; Clarkson CW Mol Cell Biochem; 2003 Dec; 254(1-2):1-7. PubMed ID: 14674677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]